X
API Suppliers
US DMFs Filed
CEP/COS Certifications
JDMFs Filed
Other Certificates
Other Suppliers
USA (Orange Book)
Europe
Canada
Australia
South Africa
Uploaded Dossiers
U.S. Medicaid
Annual Reports
0
https://www.globenewswire.com/news-release/2024/04/09/2859816/0/en/ANI-Pharmaceuticals-Announces-the-Launch-of-Baclofen-Oral-Suspension.html
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=217788
https://www.prnewswire.com/news-releases/allos-pharma-inc-expands-intellectual-property-rights-for-arbaclofen-301930753.html
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216309
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=217252
https://www.globenewswire.com/news-release/2023/05/22/2673311/0/en/Rhythm-Pharmaceuticals-and-Genpharm-Announce-Collaboration-to-Provide-IMCIVREE-setmelanotide-to-Patients-in-Gulf-Cooperation-Council-Countries.html
https://www.pharmacompass.com/pdf/news/fda-confirms-paragraph-iv-patent-litigation-for-baclofen-1656568460.pdf
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215885
https://www.globenewswire.com/news-release/2021/08/18/2282387/0/en/Albireo-and-Genpharm-Announce-Agreement-to-Commercialize-Bylvay-odevixibat-in-Saudi-Arabia-and-the-Gulf-Region.html
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-august-18-2021-1629274448.pdf
https://drugstorenews.com/beximco-receives-fda-nod-baclofen#:~:text=Beximco%20has%20received%20the%20Food,spinal%20cord%20injury%20or%20disease.
https://drugstorenews.com/beximco-receives-fda-nod-baclofen#:~:text=Beximco%20has%20received%20the%20Food,spinal%20cord%20injury%20or%20disease.
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214099
https://lawstreetmedia.com/news/health/research-co-says-competitor-misappropriated-trade-secrets-in-development-of-baclofen/
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210777
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212378
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212067
https://www.indiainfoline.com/article/news-top-story/unichem-lab-gets-usfda-nod-for-baclofen-tablets-stock-ends-higher-120071000527_1.html
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-august-7-2019-1565155577.pdf
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210315
https://www.raps.org/news-and-articles/news-articles/2019/7/fda-sends-warning-letters-to-aurobindo-api-repack?feed=Regulatory-Focus
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211555
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211659
https://www.biospace.com/article/osmotica-pharmaceuticals-plc-announces-pricing-of-initial-public-offering/
https://seekingalpha.com/article/4207220-osmotica-pharmaceuticals-files-raise-capital-u-s-ipo?source=partner_newsnow
https://www.pharmacompass.com/pdf/news/peoples-custom-rx-sterile-drug-producer-receives-fda-form-483-1536902931.pdf
https://www.prnewswire.com/news-releases/novaquest-capital-management-acquires-cutispharma-inc-300619121.html
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209592
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209102
http://www.moneycontrol.com/news/business/stocks-business/morgan-stanley-underweight-on-sun-pharma-sparcs-baclofen-grs-fails-in-phase-iii-study-2407883.html
http://www.fiercebiotech.com/biotech/galapagos-pharnext-join-forces-to-develop-drug-combos
http://www.prnewswire.com/news-releases/teligent-inc-announces-health-canada-approval-of-three-baclofen-injection-products-300318097.html
https://www.pharmacompass.com/pdf/news/sinteticas-generic-baclofen-approved-in-us-as-muscle-relaxer-antispastic-agent-1462535005.pdf
https://www.pharmacompass.com/pdf/news/us-fda-enforcement-report-16mar2016-1458126358.pdf
http://www.accessdata.fda.gov/scripts/enforcement/enforce_rpt-Product-Tabs.cfm?action=select&recall_number=D-0733-2016&w=03092016&lang=eng
http://www.accessdata.fda.gov/scripts/enforcement/enforce_rpt-Product-Tabs.cfm?action=select&recall_number=D-0569-2016&w=01272016&lang=eng
http://www.accessdata.fda.gov/scripts/enforcement/enforce_rpt-Product-Tabs.cfm?action=select&recall_number=D-0570-2016&w=01272016&lang=eng
http://www.accessdata.fda.gov/scripts/enforcement/enforce_rpt-Product-Tabs.cfm?action=select&recall_number=D-0573-2016&w=01272016&lang=eng
http://health.economictimes.indiatimes.com/news/pharma/french-drug-developer-pharnext-to-take-rare-approach-to-pricing/50200904
http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm476514.htm?source=govdelivery&utm_medium=email&utm_source=govdelivery
http://portal.anvisa.gov.br/wps/content/anvisa+portal/anvisa/sala+de+imprensa/menu+-+noticias+anos/2015/anvisa+suspende+lotes+de+medicamentos+da+uniao+quimica
http://www.fiercepharmamanufacturing.com/story/attix-pharmaceuticals-recalls-hundreds-apis-us/2015-04-30
Market Place
Share 
